[ad_1]
“The United States will continue to engage our international partners to ensure that this virus is defeated, but we will not be bound by multilateral organizations affected by the World Health Organization and corrupt China,” said White House spokesman Goode Derry.
More than 170 countries are in talks on a global plan for the Corona vaccine, known as Covax, which aims to accelerate vaccine development, ensure doses for all countries and distribute them to the most dangerous segments of each population.
The plan, co-led by the World Health Organization, the Coalition for Innovations in Epidemic Preparedness and the Global Alliance for Vaccines and Immunization, has been of interest to some members of the Trump administration and is backed by traditional allies of states. States, including Japan, Germany and Europe.
The newspaper stressed that the US decision is a guarantee by the Trump administration of its ability to win the vaccine race and eliminates the opportunity to secure doses of a group of promising vaccine candidates, describing it as a “risky approach.”
Lawrence Gustin, professor of global health law at Georgetown University, added: “The United States is embarking on a great adventure by pursuing business alone.” Of the insurance policy.
Hoyt said the United States could pursue bilateral deals with pharmaceutical companies while also participating in Kovacs, increasing the chances that they will receive some doses of the first safe vaccine.
Experts believe the idea behind Kovacs is to focus first on vaccinating people at high risk in each country, a strategy that can lead to better health outcomes and lower costs, confirmed Sir Moon, Associate Director of the Center for Global Health at the Higher Institute for International and Development Studies in Geneva. Washington’s lack of involvement makes it more difficult.
And he continued: “When the United States says it will not participate in any kind of multilateral effort to secure vaccines, this represents a real blow.” He added that “the behavior of countries with regard to vaccines in this epidemic will have political repercussions that go beyond public health. Next: Are you a trusted partner or, at the end of the day, are you putting away all your toys? for you?
A senior administration official, who spoke on condition of anonymity, revealed that the Trump administration believes it has enough advanced clinical trials of the Corona virus vaccine for it to do it on its own.
This decision by the United States follows Washington’s decision to officially withdraw from the World Health Organization last July, after it was its largest funder, due to its handling of the epidemic and its bias towards China.
J. Stephen Morrison, director of the Center for Global Health Policy at the Center for Strategic and International Studies, said the White House could still reverse course and join Kovacs, or at least allow the Senate to fund the initiative through the Global Alliance for Vaccines and Immunization.
